Field trial of oral cholera vaccines in Bangladesh. 1986

J D Clemens, and D A Sack, and J R Harris, and J Chakraborty, and M R Khan, and B F Stanton, and B A Kay, and M U Khan, and M Yunus, and W Atkinson

The protective efficacy of oral B subunit killed whole-cell (BS-WC) and killed whole-cell (WC) cholera vaccines was assessed in 63 498 Bangladeshi children aged 2-15 years and women aged over 15 years. Each received three doses of BS-WC, WC, or placebo in a randomised, double-blinded fashion. Surveillance for cases seeking medical care up to six months after the third dose revealed 26 cases of confirmed cholera in the placebo group, 4 cases in the BS-WC group (protective efficacy 85%; p less than 0.0001), and 11 cases in the WC group (protective efficacy 58%; p less than 0.01). For each vaccine protective efficacy was consistent in different age-groups (2-10 years versus greater than 10 years) and for different severities of cholera.

UI MeSH Term Description Entries
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002771 Cholera An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated. Vibrio cholerae Infection,Choleras,Infection, Vibrio cholerae,Infections, Vibrio cholerae,Vibrio cholerae Infections
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

J D Clemens, and D A Sack, and J R Harris, and J Chakraborty, and M R Khan, and B F Stanton, and B A Kay, and M U Khan, and M Yunus, and W Atkinson
January 2020, PloS one,
J D Clemens, and D A Sack, and J R Harris, and J Chakraborty, and M R Khan, and B F Stanton, and B A Kay, and M U Khan, and M Yunus, and W Atkinson
May 2019, International health,
J D Clemens, and D A Sack, and J R Harris, and J Chakraborty, and M R Khan, and B F Stanton, and B A Kay, and M U Khan, and M Yunus, and W Atkinson
April 1997, Lancet (London, England),
J D Clemens, and D A Sack, and J R Harris, and J Chakraborty, and M R Khan, and B F Stanton, and B A Kay, and M U Khan, and M Yunus, and W Atkinson
September 1986, Lancet (London, England),
J D Clemens, and D A Sack, and J R Harris, and J Chakraborty, and M R Khan, and B F Stanton, and B A Kay, and M U Khan, and M Yunus, and W Atkinson
January 2022, Vaccine,
J D Clemens, and D A Sack, and J R Harris, and J Chakraborty, and M R Khan, and B F Stanton, and B A Kay, and M U Khan, and M Yunus, and W Atkinson
March 2023, Vaccine,
J D Clemens, and D A Sack, and J R Harris, and J Chakraborty, and M R Khan, and B F Stanton, and B A Kay, and M U Khan, and M Yunus, and W Atkinson
January 1967, Bulletin of the World Health Organization,
J D Clemens, and D A Sack, and J R Harris, and J Chakraborty, and M R Khan, and B F Stanton, and B A Kay, and M U Khan, and M Yunus, and W Atkinson
June 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
J D Clemens, and D A Sack, and J R Harris, and J Chakraborty, and M R Khan, and B F Stanton, and B A Kay, and M U Khan, and M Yunus, and W Atkinson
August 1990, Lancet (London, England),
J D Clemens, and D A Sack, and J R Harris, and J Chakraborty, and M R Khan, and B F Stanton, and B A Kay, and M U Khan, and M Yunus, and W Atkinson
January 2024, The Cochrane database of systematic reviews,
Copied contents to your clipboard!